By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide.
A pair of researchers in the Department of Neurobiology and Behavior are designing new technology and research methods to discover how brain circuits support learning and memory.
Collaboration was the theme of the evening at the second annual Community Engagement Awards, held April 16 and hosted by the Einhorn Center for Community Engagement to celebrate excellence in local and global university-community partnerships.
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to evaluate a test that uses an artificial intelligence algorithm to determine whether a patient is positive for cancer.
For talkative midshipman fish, the midbrain plays a key role in patterning trains of sounds and may serve as a model for how mammals, including humans, control vocal expression.
Members of the Weill Cornell Medical College Class of 2024 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.
An experimental mRNA vaccine against human cytomegalovirus, a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any vaccine candidate, according to a study by Weill Cornell Medicine investigators.
A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.